Loading stock analysis…
Evidence Synthesis
Last synthesized: 24 Aug 2026, 04:17
Narrative updating · score is newerSee how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Lal Path Labs (LALPATHLAB) has accelerated its 60.2% gross margin, up from 25.46% in the previous quarter.
This represents a marginal operating leverage, accelerating from 18.75% in the previous quarter. The company's revenue growth has slowed down, with a year-over-year decline, down from 27.8% in the previous quarter. Despite this, the stock has seen a decrease in daily volume, with 99702 shares traded compared to 487571 shares in the previous day.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 60.2 % | 25.46 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 25.46 % | 18.75 | ▲ |
| REVENUE_GROWTH_YOY | 19.1 % | 27.8 | ▼ |
| EPS_ACTUAL | 9.005 INR | 6.733 | ▲ |
| EPS_SURPRISE_PERCENT | -0.004 % | -0.014 | ▲ |
| PRICE_CHANGE_PERCENT | -0.021 % | — | - |
| DAILY_VOLUME | 99,702 shares | 4,87,571 | ▼ |
| CLOSE_PRICE | 1,889 INR | 1,889.4 | ▼ |
| NEWS_SENTIMENT_SCORE | 0.65 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 4 count | 16 | ▼ |
| TARGET_PRICE_PREMIUM | 2.06 % | — | - |